Pratia, a large site network, has joined The Association of Multisite Research Corporations (AMRC) as its fifteenth member.

AMRC is a non-profit organization dedicated to advancing the use of multisite clinical research corporations in the global clinical trial ecosystem. With this addition, AMRC now represents a collective footprint of nearly 500 research sites, almost 8,000 employees, and approximately 1,500 principal investigators across its member companies, globally.

Launched earlier this year, AMRC’s members are independent of sponsors, CROs, and academic centers, united instead by a shared belief in the value of MCRCs to expedite patient recruitment and improve data collection and quality.

Pratia’s membership not only bolsters AMRC’s global representation but strengthens the group’s advocacy in oncology research. Headquartered in Poland, Pratia, a Humaneva group entity, operates a technology-enabled clinical site network spanning seven European countries and the United States. With over 100 locations and a commitment to patient-centricity and operational excellence, Pratia exemplifies the modern, scalable research infrastructure that AMRC was formed to represent.

Mona Alqam, MD, Pratia Country Head, USA, commented: “As clinical research continues to evolve under mounting pressure on Sponsors and CROs to accelerate timelines, reduce costs, and increase trial access, AMRC provides a vital platform to advance a new, more efficient model for trial delivery, which is why Pratia chose to join.”

Pratia’s membership further strengthens AMRC’s European presence and affirms the association’s growing role as the global advocate for this emerging sector of MCRCs within the clinical trials industry.